SCARLETT JOHN A 4
4 · GERON CORP · Filed Jun 7, 2024
Insider Transaction Report
Form 4
GERON CORPGERN
SCARLETT JOHN A
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-06-06+1,000,000→ 1,000,000 totalExercise: $1.72Exp: 2028-11-06→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.